Starrex Files Restated Q2 2015 Interim Financial Statements and Revised MD&A and Updates Previous Disclosure


TORONTO, ONTARIO--(Marketwired - April 4, 2016) - Starrex International Ltd. ("Starrex" or the "Company") (CSE:STX) filed on Friday, April 1, 2016 amended and restated interim financial statements and a revised management discussion and analysis ("MD&A") for the second-quarter ended June 30, 2015 (collectively, the "Second Interim Restatements") which can be found on SEDAR (www.sedar.com) under the Company's profile. This followed the filing on Friday, March 18, 2016 of restated audited financial statements and a revised management discussion and analysis for the Company for the year ended December 31, 2014 (see press release dated March 18, 2016), and the filing on March 24, 2016 of restated unaudited financial and a revised management discussion and analysis for the Company for the first quarter ending March 31, 2015 (see press release dated March 28, 2016).

On December 9 and 16, 2015, after discussions with the staff of the Ontario Securities Commission ("OSC") Starrex announced that it would restate and re-file (i) its first, second and third quarter unaudited interim financial statements for the periods ended March 31, June 30 and September 30, 2015; and (ii) the corresponding interim MD&As. Following additional discussions with the OSC respecting the treatment of the subsidiaries, Property Interlink, LLC, One Force Staffing, Inc. and Olympia Capital Management, Inc., acquired by Starrex on July 9, 2014 (the "Acquisitions"), Starrex announced on February 8, 2016 that it would restate and refile its 2014 audited annual financial statements. The restatement and refiling of the 2015 interim financial statements were delayed pending completion of the restatement of the 2014 audited annual financial statements.

Subsequent to the original issuance of the Company's unaudited condensed interim consolidated financial statements as at June 30, 2015, the Company determined that the share consideration issued in exchange for the acquisitions completed July 9, 2014 was incorrectly measured using the concurrent financing price of CAD$0.50. These restated unaudited condensed interim consolidated financial statements reflect an increased value allocated to the share consideration issued in exchange for the acquisitions based on the trading price of the Company's stock on the close date of the acquisitions, being CAD$0.95 per share. Furthermore, the original issuance of the December 31, 2014 consolidated financial statements included an unallocated purchase price as management had not yet completed the measurement and recognition of identifiable assets and liabilities included in the purchase price allocation. These restated unaudited condensed interim consolidated financial statements include the finalized purchase price allocation which resulted in the recognition of additional intangible assets and amortization related thereto as well as goodwill (Note 8). The restatement of the Company's unaudited condensed interim consolidated financial statements reflects corrections in intangible assets, goodwill, deferred tax liability, share capital, and deficit as well as amortization of intangible assets. These unaudited condensed interim consolidated financial statements include adjustments to certain items in the condensed interim consolidated statement of financial position to the appropriate presentation for the discontinued operations.

For presentation purposes, deferred revenue in the original statement of financial position was included in the balances for accrued liabilities. For further clarification, deferred revenue has been presented separately for comparative purposes, which flow through the consolidated statement of cash flows as appropriate.

As a result of the correction for the acquisitions noted above there was a change to the cumulative translation adjustment which has been presented as appropriate through accumulated other comprehensive income.

Effects of restatement

The following tables reflect the changes to the Company's consolidated financial statements for the period ended June 30, 2015.

Changes to the condensed interim consolidated statements of financial position:
As previously reported June 30, 2015 Adjustment Restated June 30, 2015
Other current assets $ 898,494 $ (898,494 ) $ -
Notes receivable - current $ - $ 965,000 $ 965,000
Property, plant and equipment, net of depreciation $ 373,057 $ 4,420 $ 377,477
Intangible assets $ 217,386 $ 567,303 $ 784,689
Goodwill $ - $ 573,999 $ 573,999
Unallocated purchase price $ 974,336 $ (974,336 ) $ -
Total assets $ 4,620,403 $ 237,892 $ 4,858,295
Accounts payable and accrued liabilities $ 387,096 $ (135,116 ) $ 251,980
Deferred revenue $ - $ 276,856 $ 276,856
Notes payable - current $ - $ 110,060 $ 110,060
Notes payable - long term $ 210,741 $ (110,060 ) $ 100,681
Deferred tax liability $ 355,420 $ 15,522 $ 370,942
Total liabilities $ 993,418 $ 157,262 $ 1,150,680
Share capital $ 5,138,672 $ 1,606,979 $ 6,745,651
Contributed surplus $ 148,203 $ 3,708 $ 151,911
Accumulated other comprehensive income $ (232,109 ) $ (29,425 ) $ (261,534 )
Deficit $ (1,427,781 ) $ (1,500,632 ) $ (2,928,413 )
Total equity $ 3,626,985 $ 80,630 $ 3,707,615
Total equity and liabilities $ 4,620,403 $ 237,892 $ 4,858,295
Changes to the condensed interim consolidated statements of loss and comprehensive loss:
As previously reported 6 months ended June 30, 2015 Restatement Adjustment Restated 6 months ended June 30, 2015 As previously reported 3 months ended June 30, 2015 Restatement Adjustment Restated 3 months ended June 30, 2015
Amortization $ 6,714 $ 57,918 $ 64,632 $ 3,357 $ 27,991 $ 31,348
Depreciation $ 26,471 $ 11,792 $ 38,263 $ 14,127 $ 837 $ 14,964
Share based payments $ - $ 3,707 $ 3,707 $ - $ 3,707 $ 3,707
Net (loss) income from continuing operations $ (29,342 ) $ (73,417 ) $ (102,759 ) $ 10,969 $ 68,565 $ 79,534
Loss from discontinued operations $ - $ (476,822 ) $ (476,822 ) $ - $ (321,908 ) $ (321,908 )
Net comprehensive loss $ (29,342 ) $ (550,239 ) $ (579,581 ) $ 10,969 $ (253,343 ) $ (242,374 )
Basic and diluted loss per share from continuing operations $ - $ (0.01 ) $ (0.01 ) $ - $ (0.02 ) $ (0.02 )
Basic and diluted loss per share from discontinuing operations $ - $ (0.03 ) $ (0.03 ) $ - $ (0.02 ) $ (0.02 )
Changes to the condensed interim consolidated statements of cash flows:
As previously reported June 30, 2015 Restatement Adjustment Restated June 30, 2015
Net loss for the year $ (29,342 ) $ (73,417 ) $ (102,759 )
Loss on discontinued operations $ - $ (476,822 ) $ (476,822 )
Stock based compensation $ - $ $ 3,707
Deprecation and amortization $ 33,185 $ 69,710 $ 102,895
Unpaid interest $ - $ 5,936 $ 5,936
Prepaid expenses $ (40,656 ) $ 9,725 $ (30,931 )
Accounts receivable $ (301,472 ) $ 274,664 $ (26,808 )
Accounts payable and accrued liabilities $ 387,096 $ (333,909 ) $ 53,187
Income taxes payable $ 40,161 $ (40,161 ) $ -
Deferred revenue $ - $ (186,249 ) $ (186,249 )
Deferred tax liability $ - $ (65,220 ) $ (65,220 )
Cash generated from (used in) operating activities from discontinued operations $ - $ 196,791 $ 196,791
Purchase of property, plant and equipment $ - $ (66,692 ) $ (66,692 )
Purchase of intangible assets $ - $ (95,124 ) $ (95,124 )
Divestiture of subsidiary $ (632,957 ) $ 632,957 $ -
Principal repayment on notes payable $ - $ (46,523 ) $ (46,523 )

As previously announced, the OSC issued a management cease trade order ("MCTO") prohibiting the Company's Chief Executive Officer and Chief Financial Officer from trading, directly or indirectly, in the securities of Starrex until two full business days following the receipt by the OSC and filing of all filings which Starrex is required to make under Ontario securities law, namely the restated 2014 audited annual financial statements, along with restatements of the first three quarterly financial statements of 2015, and all related revised MD&As. Starrex expects to file restated interim financial statements for the period ended September 30, 2015, and the related revised interim MD&A, by the end of this week, which would complete all its refiling obligations.

Starrex intends to satisfy the provisions of the Alternative Information Guidelines as set out in National Policy 12-203 for as long as Starrex remains in default, including the issuance of further bi-weekly (or sooner) default status reports, each of which will be issued in the form of a press release. A general cease trade order may be issued if Starrex fails to file such default status reports on a timely basis. The MCTO does not affect the ability of persons who are not insiders of Starrex to trade its securities.

This news release contains forward-looking information. All information other than statements of historical fact that address activities, events or developments that Starrex believes, expects or anticipates will or may occur in the future are forward-looking statements, including statements regarding filing of the amended and restated quarterly unaudited financial statements and related management's discussions and analyses. This forward-looking information is subject to a variety of risks and uncertainties beyond Starrex's ability to control or predict that may cause actual events or results to differ materially from those described in such forward-looking information. Any forward-looking information speaks only as of the date on which it is made and, except as may be required by applicable securities laws, Starrex disclaims any intent or obligation to update any forward-looking information, whether as a result of new information, future events or results or otherwise. Although Starrex believes that the assumptions inherent in the forward-looking information are reasonable, forward-looking information is not a guarantee of future performance and accordingly undue reliance should not be placed on this forward-looking information due to the inherent uncertainty thereof.

This news release does not constitute an offer to sell or a solicitation of an offer to buy any securities in the United States. The Company's securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.

Neither IIROC nor any stock exchange or other securities regulatory authority accepts responsibility for the adequacy or accuracy of this press release.

Contact Information:

Starrex International Ltd.
Ronald Mann
Secretary, Chief Operating Officer
and Investor Relations Officer
(647) 981-2782
rmann@starrexintl.com